Enzyme replacement therapy with alglucosidase alfa in Pompe disease: Clinical experience with rate escalation

Patients with Pompe disease have realized significant medical benefits due to enzyme replacement therapy (ERT) infusions with alglucosidase alfa. However, regular infusions are time-consuming. Utilizing recommended infusion rates, infusion duration is 3 hours 45 minutes for a patient receiving the s...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Genet Metab
Päätekijät: Desai, Ankit K., Walters, Crista K., Cope, Heidi L., Kazi, Zoheb B., DeArmey, Stephanie M., Kishnani, Priya S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808871/
https://ncbi.nlm.nih.gov/pubmed/29289479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgme.2017.12.435
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia